FHTX
Foghorn Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.87
+1.08%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 10.34x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.37x
- Price / sales
- 3.02x
- Price / cash flow
- -1.30x
Enterprise value
- Enterprise value
- -$13.4M
- EV / sales
- -0.37x
- EV / EBITDA
- 0.22x
- EV / EBIT
- 0.20x
- Market cap
- $111.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026